Remission Up for Mepolizumab in Eosinophilic Granulomatosis
Significantly more weeks of accrued remission for mepolizumab treatment versus placebo
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Cardiology, Internal Medicine, Allergy, Pharmacy, Pulmonology, Rheumatology, Journal, Source Type: news
More News: Allergy | Allergy & Immunology | Cardiology | Heart | Internal Medicine | Respiratory Medicine | Rheumatology